Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

Br J Cancer. 2020 Apr;122(8):1271. doi: 10.1038/s41416-020-0766-1.

¹ Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
² Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
³ Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
⁴ Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Ina, Saitama, Japan.
⁵ Division of Gastroenterology, Chiba Cancer Center, Chiba, Chiba, Japan.
⁶ Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
⁷ Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Hokkaido, Japan.
⁸ Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Fukuoka, Japan.
⁹ Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
¹⁰ Scientific Affairs Division, Clinical Affairs, Sysmex Corporation, Kobe, Hyogo, Japan.
¹¹ Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.
¹² Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. tyoshino@east.ncc.go.jp.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.